ID: ALA3895716

Max Phase: Preclinical

Molecular Formula: C19H22N6O7S

Molecular Weight: 478.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4c5ccccc5C[C@@H]4O)ncnc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C19H22N6O7S/c20-33(29,30)31-6-12-15(27)16(28)19(32-12)25-8-23-14-17(21-7-22-18(14)25)24-13-10-4-2-1-3-9(10)5-11(13)26/h1-4,7-8,11-13,15-16,19,26-28H,5-6H2,(H2,20,29,30)(H,21,22,24)/t11-,12+,13+,15+,16+,19+/m0/s1

Standard InChI Key:  JKNADMJNGXJOCA-ZVWXDJDZSA-N

Associated Targets(Human)

NEDD8-activating enzyme E1 catalytic subunit 128 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 478.49Molecular Weight (Monoisotopic): 478.1271AlogP: -1.26#Rotatable Bonds: 6
Polar Surface Area: 194.94Molecular Species: NEUTRALHBA: 12HBD: 5
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.30CX Basic pKa: 4.64CX LogP: -1.12CX LogD: -1.12
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.28Np Likeness Score: 0.46

References

1.  (2006)  Inhibitors of E1 activating enzymes, 

Source